Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian I Rini

Showing results (1-10 of 401) with videos related to

Pageof 41
Sort By:
Current Opinion in Urology|August 15, 2006
Current status and future directions of molecular markers in renal cell carcinomaBrian I Rini
Urologic Oncology|May 12, 2005
New approaches in advanced renal cell carcinomaBrian I Rini
Clinical Advances in Hematology & Oncology : H&O|May 12, 2011
Review: thyroid function abnormalities in patients receiving VEGF-targeted therapyBrian I Rini
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
New strategies in kidney cancer: therapeutic advances through understanding the molecular basis of response and resistanceBrian I Rini
Expert Opinion on Pharmacotherapy|October 12, 2007
SunitinibBrian I Rini
Current Oncology Reports|April 2, 2009
Circulating tumor cells in metastatic castration-resistant prostate cancerBrian I Rini
Expert Opinion on Pharmacotherapy|March 1, 2006
SorafenibBrian I Rini
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Metastatic renal cell carcinoma: many treatment options, one patientBrian I Rini
Current Opinion in Molecular Therapeutics|March 9, 2002
Technology evaluation: APC-8015, DendreonBrian I Rini
Clinical Genitourinary Cancer|January 24, 2006
SU11248 and AG013736: current data and future trials in renal cell carcinomaBrian I Rini
Pageof 41

Showing results (1-10 of 401) with videos related to

Sort By:
Pageof 41
Current Opinion in Urology|August 15, 2006
Current status and future directions of molecular markers in renal cell carcinomaBrian I Rini
Urologic Oncology|May 12, 2005
New approaches in advanced renal cell carcinomaBrian I Rini
Clinical Advances in Hematology & Oncology : H&O|May 12, 2011
Review: thyroid function abnormalities in patients receiving VEGF-targeted therapyBrian I Rini
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
New strategies in kidney cancer: therapeutic advances through understanding the molecular basis of response and resistanceBrian I Rini
Expert Opinion on Pharmacotherapy|October 12, 2007
SunitinibBrian I Rini
Current Oncology Reports|April 2, 2009
Circulating tumor cells in metastatic castration-resistant prostate cancerBrian I Rini
Expert Opinion on Pharmacotherapy|March 1, 2006
SorafenibBrian I Rini
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Metastatic renal cell carcinoma: many treatment options, one patientBrian I Rini
Current Opinion in Molecular Therapeutics|March 9, 2002
Technology evaluation: APC-8015, DendreonBrian I Rini
Clinical Genitourinary Cancer|January 24, 2006
SU11248 and AG013736: current data and future trials in renal cell carcinomaBrian I Rini
Pageof 41